Bicocca Open Archive

Logo unimib boa

Chiricozzi, A., Di Nardo, L., Talamonti, M., Galluzzo, M., De Simone, C., Fabbrocini, G., et al. (2022). Patients Withdrawing Dupilumab Monotherapy for COVID-19-Related Reasons Showed Similar Disease Course Compared With Patients Continuing Dupilumab Therapy. DERMATITIS, 33(3), 25-29 [10.1097/DER.0000000000000814].

Patients Withdrawing Dupilumab Monotherapy for COVID-19-Related Reasons Showed Similar Disease Course Compared With Patients Continuing Dupilumab Therapy

Carugno, A.;
2022
Lettera in rivista
dupilumab; monoclonal antibody, atopic dermatitis; disease exacerbation; human; treatment outcome, Antibodies, Monoclonal, Humanized; COVID-19; Dermatitis, Atopic; Disease Progression; Humans; Treatment Outcome;
English
2022
DERMATITIS
33
3
25
29
reserved
Chiricozzi, A., Di Nardo, L., Talamonti, M., Galluzzo, M., De Simone, C., Fabbrocini, G., et al. (2022). Patients Withdrawing Dupilumab Monotherapy for COVID-19-Related Reasons Showed Similar Disease Course Compared With Patients Continuing Dupilumab Therapy. DERMATITIS, 33(3), 25-29 [10.1097/DER.0000000000000814].
01 - Articolo su rivista
File in questo prodotto:
File Dimensione Formato  
Chiricozzi-2022-Dermatitis-VoR.pdf

Solo gestori archivio

Descrizione: Letter to the Editor
Tipologia di allegato: Publisher’s Version (Version of Record, VoR)
Licenza: Tutti i diritti riservati
Dimensione 147.04 kB
Formato Adobe PDF
  Visualizza/Apri   Richiedi una copia
147.04 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/390751
Citazioni
  • Scopus 2
  • ???jsp.display-item.citation.isi??? 1
Social impact